SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Decentraland

Decentraland ($MANA) is trending due to enthusiastic community discussions surrounding potential Apple partnerships and the platform's ongoing efforts to enable Apple Pay for broader mobile adoption. While some investors express skepticism about the metaverse's long-term utility, a significant segment is actively accumulating, anticipating a major resurgence for the sector during an upcoming altcoin season.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is trending amidst several key developments, including a recent Kraken listing, a new institutional custody partnership with Crypto.com, and ongoing ecosystem enhancements like the Hayabusa update and VeBetterDAO progress. While many investors view current price levels as a significant accumulation opportunity, anticipating a strong altcoin run, a vocal segment of the community expresses deep frustration over VET's sustained underperformance despite these positive announcements.

Wishing Well

WISH CRYPTO is gaining traction as community members are actively discussing its unique deflationary tokenomics, which include monthly token burns tied to US inflation rates. The project is seen as a long-term hold and a 'digital wishing well,' aiming to reward HODLers and distinguish itself from typical memecoins. Recent platform listings and ongoing community initiatives are fueling significant engagement and anticipation among its supporters.

Boyd Gaming Corp. is a multi-jurisdictional gaming company, which engages in the management and operation of gaming and entertainment properties. It operates through the following segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Las Vegas Locals segment consists of eight casinos that primarily serve the resident population in the Las Vegas metropolitan area. The Downtown Las Vegas segment refers to the following casinos: California Hotel and Casino, Fremont Hotel and Casino, and Main Street Station Hotel and Casino. The Midwest and South segment includes four land-based casinos, six dockside riverboat casinos, three racinos, and four barge-based casinos that operate in nine states in the Midwest and southern United States. The Online segment includes the operating results of online gaming operations. The company was founded by William Samuel Boyd and Sam Boyd on January 1, 1975 and is headquartered in Las Vegas, NV.

Boyd Gaming Corp.

Boyd Gaming (BYD) is trending due to a wave of analyst upgrades and increased price targets, signaling confidence in its recent earnings performance and strategic financial moves. The company's consistent operational results, substantial share repurchase authorizations, and a significant FanDuel stake sale for debt reduction are key discussion points. Concurrently, there is considerable community buzz regarding Boyd Gaming's reported interest in acquiring Penn Entertainment, though online discussions frequently confuse the casino operator with the Chinese electric vehicle manufacturer, BYDDF.

AXS is the governance token for the Axie Infinity game. Token holders will be able to shape and vote for the direction of the game universe. This is unlike traditional games where all decisions are made by the game developers. AXS holders will be able to stake their tokens to earn more AXS and even vote for governance proposals.

Axie Infinity

Axie Infinity (AXS) is experiencing renewed community interest and strong trading volume, with many anticipating a significant upward price movement. Discussions across the community highlight its potential as a 'weekend runner' and draw comparisons to its historical performance, fueling excitement within the broader crypto gaming and metaverse sectors.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

LIT CRYPTO is experiencing extreme volatility and intense community discussion amid conflicting reports regarding its trading status on major exchanges, with some users reporting a delisting while others anticipate a relisting or a migration to a new token, Heima (HEI). This immediate uncertainty, combined with speculative mentions of new "Trump NFTs," is driving aggressive buying for quick gains but also strong warnings about pump-and-dump risks, making it a highly discussed and risky asset.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending with significant community buzz following its integration with World Liberty Finance for USD1 payroll and card solutions, alongside the imminent launch of its Super App. Enthusiastic investors are highlighting ZBCN's real-world utility, ISO 20022 compliance, and robust partnerships, viewing it as a highly undervalued token ripe for long-term accumulation and staking.

Tower Semiconductor Ltd. engages in providing semiconductor solutions. It also offers technology and manufacturing platforms for integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, mobile, infrastructure, medical, and aerospace and defense. It focuses on creating positive and sustainable impact on the world through long term partnerships and its advanced and innovative analog technology offering, comprised of a broad range of customizable process platforms such as SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, non-imaging sensors, integrated power management (BCD and 700V), and MEMS. Its designs enable a quick and accurate design cycle as well as process transfer services including development, transfer, and optimization, to IDMs and fabless companies. The company was founded in 1993 and is headquartered in Migdal Haemek, Israel.

Tower Semiconductor Ltd.

Tower Semiconductor (TSEM) is a hot topic after its acquisition by Intel was terminated, receiving a $353 million termination fee. This quickly pivoted to a new strategic foundry agreement where TSEM gains significant 300mm capacity at Intel's New Mexico facility, fueling community sentiment that TSEM is an undervalued leader in the booming AI and Silicon Photonics market.

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is currently a focal point in community discussions regarding its approach to new dialysis therapies. There's active scrutiny over the revenue impact of Akebia's Vafseo despite wider access, while significant concern and frustration are voiced over DaVita's apparent non-adoption of Cormedix's DefenCath. The community is questioning why the company isn't utilizing this proven solution to reduce deadly bloodstream infections, especially given its use by competitors and implications for patient safety.

SSgA Active Trust - State Street Industrial Select Sector SPDR ETF

Industrial Select Sector SPDR Fund

XLI is trending due to robust industrial production growth and renewed optimism for the manufacturing sector, frequently noted for achieving new all-time highs. The community is actively discussing its strong leadership in a market rotation towards cyclical sectors, with many highlighting its ongoing bullish momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc.

QRG Capital Management Inc. reduced its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 24.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The...

Gilead Sciences (NASDAQ:GILD) Insider Sells $372,930.00 in Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) insider Johanna Mercier sold 3,000 shares of the company's stock in a transaction that occurred on Thursday, January 15th. The shares were sold...

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares of Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) insider Johanna Mercier sold 3,000 shares of the company's stock in a transaction dated Thursday, January 15th. The stock was sold at an average...

Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) CFO Andrew Dickinson sold 3,000 shares of the company's stock in a transaction dated Thursday, January 15th. The shares were sold at an average...

Looking Into Gilead Sciences Inc's Recent Short Interest

Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 10.7% during the third quarter, according to the company in its most recent filing...

Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc.

Conning Inc. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 8.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 291,475 shares of the...

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Gilead Sciences (GILD) closed at $122.59, indicating a +1.23% shift from the previous trading day.

Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history

Daniel O'Day, Gilead Sciences CEO and chairman, joins 'Squawk Box' to discuss the advances in medicine, what to expect at the JPMorgan Healthcare Conference today, the company's Yeztugo HIV...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Current Price	$124.91
Prev Close	$121.26
Open	$123.80
Dividend Yield	3.33%
50-Day Moving Average	$123.13
Beta	0.35
Avg. Volume	6.61M
PE Ratio	19.35

52-Week High	$128.70
52-Week Low	$91.84
Market Capitalization	$154.97B
EPS (Annual)	$0.3825
Price to Book	7.20
Revenue Per Employee	$1.63M
Enterprise Value/EBITDA	N/A

GILD
Gilead Sciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GILD News

GILDGilead Sciences, Inc.